CHEK2 and cancer: An investigation to observe how common germline mutations are in genes that contribute to cancer susceptibility among patients with advanced renal cell carcinoma revealed that out of 254 patients, 41 (16.1%) had germline mutations, and the most frequent mutations were found in the CHEK2 gene (28).